Presystemic Elimination

Presystemic Elimination is a pharmacokinetic phenomenon characterized by the metabolic degradation of an administered drug during its initial passage through the liver prior to entering the systemic circulation, thereby reducing its bioavailability.

41

Publications

1.7K

Citations

172

Authors

50

Institutions

Publications per year

2017–2026

1

Authors

172

  1. CG
    C G Regårdh

    AstraZeneca (Sweden), Sweden

    2 publications · 158 citations

    2

    h-index

  2. OR
    Ola Rönn

    Sahlgrenska University Hospital, Sweden

    2 publications · 158 citations

    2

    h-index

  3. BE
    Boo Edgar

    University of Gothenburg, Sweden

    2 publications · 158 citations

    2

    h-index

  4. YW
    Yie W. Chien

    Rutgers, The State University of New Jersey, United States

    2 publications · 255 citations

    2

    h-index

  5. PL
    Per Lundborg

    University of Gothenburg, Sweden

    2 publications · 158 citations

    2

    h-index

1–5 of 172

Venues

  1. PubMed

    Repository · 6 publications · 342 citations

    6

    h-index

  2. 4

    h-index

  3. Clinical Pharmacology & Therapeutics

    CPT · 3 publications · 196 citations

    3

    h-index

  4. British Journal of Clinical Pharmacology

    BJCP · 3 publications · 57 citations

    3

    h-index

  5. Biopharmaceutics & Drug Disposition

    3 publications · 143 citations

    3

    h-index

1–5